MIRCIM Program

Open forum on critical care, shock, and organ failure
Waleed Alhazzani (Saudi Arabia), Michael Czekajlo (USA), Kimia Honarmand (Canada), Roman Jaeschke (Canada), Simon Oczkowski (Canada), Bram Rochwerg (Canada), Wojciech Szczeklik (Poland)

In collaboration with the Polish Society of Endocrinology

9:40–10:00
Hypothyroidism in pregnancy: When guidelines meet reality
Robin Peeters (The Netherlands)

10:00–10:20
Primary aldosteronism: Current management
Ally Prebtani (Canada)

10:20–10:40
Hypercortisolemia: Current management according to clinical practice guidelines
Aleksandra Gilis-Januszewska (Poland)

10:40–11:05
Questions & Answers
All speakers

In collaboration with the Polish Cardiac Society 

11:25–11:45
2025 international guidelines on resuscitation: The most important practical messages
Bernd W. Böttiger (Germany)

11:45–12:05
Management of pericarditis: Key messages from the ESC guidelines
Massimo Imazio (Italy)

12:05–12:25
Management of myocarditis: Key messages from ESC guidelines
To be announced

12:25–12:50
Questions & Answers
All speakers

13:40–14:00
Mitral regurgitation: Management according to ESC practice guidelines
Margarita Brida (Croatia)

14:00–14:20
Aortic stenosis: Management according to ESC practice guidelines
Wojciech Wojakowski (Poland)

14:20–14:40
How to select an antiarrhythmic drug or ablation for atrial fibrillation and for ventricular tachycardia
Paulus Kirchhof (Germany)

14:40–15:05
Questions & Answers
All speakers

15:25–15:45
Broken-heart syndrome: Current management
Thomas Lüscher (Switzerland)

15:45–16:05
Optimal use of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease according to current practice guidelines
Richard Češka (Czech Republic)

16:05–16:25
Coronary artery disease: Which diagnostic test to choose and when
Matthew Sibbald (Canada)

16:25–16:50
Questions & Answers
All speakers

Under the auspices of the European Federation of Internal Medicine

9:40–10:00
How to modify pharmacotherapy of primary arterial hypertension in multimorbid patients
Krzysztof Narkiewicz (Poland)

10:00–10:20
GLP1-RA and multimorbidity: Beyond expectations
Michał Holecki (Poland)

10:20–10:40
Management of chronic pain in multimorbid patients
Marcin Chwistek (USA)

10:40–11:05
Questions & Answers
All speakers

11:25–11:45
Key decision points in management of rheumatoid arthritis
Ernest Choy (UK)

11:45–12:05
Key decision points in management of Sjögren disease
Elizabeth Price (UK)

12:05–12:25
Artificial Intelligence in rheumatology: 2026 update
Thomas Hügle (Switzerland)

12:25–12:50
Questions & Answers
All speakers

13:40–14:00
Vasculitis: From suspicion to diagnosis
To be announced

14:00–14:20
Key decision points in management of the GCA PMR Takayasu LVV spectrum
Bhaskar Dasgupta (UK)

14:20–14:40
Approach to interstitial lung disease in people with systemic autoimmune rheumatic diseases
Michal Tomcik (Czechia)

14:40–15:05
Questions & Answers
All speakers

15:25–15:45
Key decision points in management of axial spondyloarthritis
Elena Nikiphorou (UK)

15:45–16:05
Key decision points in management of psoriatic arthritis
William Tillett (UK)

16:05–16:25
Key decision points in management of osteoporosis
Alexandra Papaioannou (Canada)

16:25–16:50
Questions & Answers
All speakers

9:30–9:50
Gastroenterology update 2026: Key messages from the latest practice guidelines
Paul Moayyedi (Canada)

9:50–10:10
Celiac disease: Current management
Maria Pinto-Sanchez (Canada)

10:10–10:30
Screening for all cancers (with a focus on all GI cancer) with blood tests or total body scans: Is it worth it?
David Weinberg (USA)

10:30–10:55
Questions & Answers
All speakers

11:10–11:30
Current management of chronic obstructive pulmonary disease: 2026 update
Jadwiga Wedzicha (UK)

11:30–11:50
Asthma diagnosis: A complex pathway to clarity
Imran Satia (Canada)

11:50–12:10
To be announced

12:10–12:35
Questions & Answers
All speakers

Under auspices of the European Association for the Study of Diabetes and the International Diabetes Federation Europe

13:35-13:55
A Type 1 diabetes management consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD): What can we expect from the 2026 update?
Tomasz Klupa (Poland)

13:55-14:15
Is there still a place for insulin therapy in type 2 diabetes in 2026?
Maciej Małecki (Poland)

14:15-14:35
Diabetic patient admitted to hospital for non-diabetic reason
Ally Prebtani (Canada)

14:35-15:00
Questions & Answers
All speakers

15:15-15:35
Prediabetes: really just “Pre”? Pharmacological treatment options based on the patient's phenotype and clinical profile
Leszek Czupryniak (Poland)

15:35-15:55
Diabetes treatment in older age groups: Is there consistency between guidelines and common sense?
Tali Cukierman-Yaffe (Israel)

15:55-16:15
What are the evidence-based recommendations for the dietary management of diabetes?
Dario Rahelić (Croatia)

16:15-16:35
In the era of drugs that effectively reduce body weight and normalize glycemia, is there still a place for bariatric surgery?
Johanna Brix (Austria)

16:35-17:00
Questions & Answers
All speakers

9:30–9:50
Vaccinations for people with severe comorbidity: Current state of the art
Mark Loeb (Canada)

9:50–10:10
HIV and AIDS in 2026: An update for non-specialists
Monika Bociąga-Jasik (Poland)

10:10–10:30
Applying antibiotic stewardship in patient care
Nishma Singhal (Canada)

10:30–10:55
Questions & Answers
All speakers

11:10–11:15
Introduction
Jack Hirsch (Canada)

11:15–11:40
When not to use DOACs
Stephanie Carlin (Canada)

11:40–12:05
Factor XI inhibitors: The future of anticoagulation?
Jeffrey Weitz (Canada)

12:05–12:10
Conclusion
Jack Hirsch (Canada)

12:10–12:35
Questions & Answers
All speakers

Under the auspices of Mayo Clinic

9:30–9:50
Nephrology update 2026
Jurgen Floge (Germany)

9:50–10:10
New drugs in chronic kidney disease
Maria José Soler (Spain)

10:10–10:30
Artificial intelligence in nephrology
Ziad Zoghby (USA)

10:30–10:55
Questions & Answers
All speakers

11:10–11:30
Hyperglycemia and kidney disease
Aleksandra Kukla (USA)

11:30–11:50
Bleeding complications and thrombosis events in kidney disease
Hatem Amer (USA)

11:50–12:10
Nephrotoxicity of new anti-cancer agents
Sandra Herrmann (USA)

12:10–12:35
Questions & Answers
All speakers

13:35–13:55
New paradigms in the treatment of renovascular disease
Lilach Lerman (USA)

13:55–14:15
Blood pressure goals and treatment in pregnancy
Andrea G. Kattah (USA)

14:15–14:35
Preeclampsia: What internist should know
Vesna D. Garovic (USA)

14:35–15:00
Questions & Answers
All speakers

15:15–15:35
Lupus nephritis: Redefining treatment goals
Fernando Fervenza (USA)

15:35–15:55
Monoclonal gammopathy and kidney
Ladan Zand (USA)

15:55–16:15
When to think about genetic testing in kidney disease
Mireille El Ters (USA)

16:15–17:00
Open panel discussion